Epigenomics Competitors and Similar CompaniesClear all
Epigenomics's competitors and similar companies include Indi Molecular and SD Biosensor.
 Epigenomics Epigenomics AG isa molecular diagnostics company developing and manufacturinga pipeline of products for the diagnosis of cancer. |  Indi Molecular Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. | ||
Founding Date | Founding Date 1998 | Founding Date 2013 | Founding Date 2010 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Berlin, DE HQ San Diego, US | Locations Culver City, US HQ | Locations Suwon, KR HQ Shanghai, CN Gurugram, IN Purwakarta, ID Cheongwon Gun, KR Gumi, KR Pyeongtaek, KR see more |
Employees | Employees 329% decrease | Employees 30 | Employees 5952% increase |
Financial | |||
Revenue (est.) | Revenue (est.) €24k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩710.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩347.9b (FY, 2025) |
Gross profit | Gross profit €31k (FY, 2025) | Gross profit N/A | Gross profit ₩373.8b (FY, 2025) |
Net income | Net income (€314k) (FY, 2025) | Net income N/A | Net income (₩513.4b) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 11.7m | Total funding raised $ 11.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Indi Molecular
HQ
Culver City, US
Employees
30
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.
View company
SD Biosensor
HQ
Suwon, KR
Employees
595↑ 2% increase
SD Biosensor is an in-vitro diagnostic company.
View company